hair loss on tirzepatide Improvement of Recalcitrant Folliculitis Decalvans With Tirzepatide: A Case Report Tirzepatide and Hair Loss: What

HR = 0.71

Treatment with semaglutide reduces risk of death or morbidity from cardiovascular disease- in the SUSTAIN 6 trial (104 weeks, 3297 patients with diabetes and high cardiovascular risk), the risk of developing cardiovascular death, myocardial infarction (heart attack) or stroke was reduced by 26% in the patients treated with semaglutide (Ozempic)

A newer GLP-1 receptor agonist, tirzepatide, demonstrates weight loss as high as 20% change in body weight compared with 3% in the placebo group in a RCT

An international team of researchers wanted to assess whether or not taking these drugs was linked to an impact on mental health issues